IP Library › Granted Patent US 12,508,428
Granted Patent B2
US 12,508,428 · App. 18/101,799 · Granted Dec 30, 2025

Respiratory-based cardiac remodeling pacing therapy

Inventors: Matthew J. Hoffman (St. Paul, MN); Troy E. Jackson (Rogers, MN); Michael D. Eggen (Chisago City, MN)
Assignee: Medtronic, Inc.
A61N1/36514A61N1/3702
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,508,428
App. No.
18/101,799
Granted
Dec 30, 2025
Kind
B2
Abstract

Systems, devices, and methods for performing respiratory-based cardiac remodeling pacing therapy are described in this disclosure. A patent's respiration may be monitored, and the lower pacing limit for the cardiac remodeling pacing and support pacing therapy delivered to a patient may be adjusted based on the monitored respiration to achieve or restore respiratory sinus arrhythmia.

Claims (63)

1 . An implantable medical device comprising:

a pacing electrode to be positioned proximate a patient's heart to deliver pacing therapy to the patient's heart;

a respiration sensor to determine the patient's respiration rate; and

a computing apparatus operably coupled to the pacing electrode and the respiration sensor, the computing apparatus configured to:

deliver pacing to the patient's heart using at least the pacing electrode based on a lower rate limit, wherein the lower rate limit is a minimum pacing rate delivered to the patient,

monitor the patient's respiration using the respiration sensor,

adjust the lower rate limit based on the patient's respiration to restore respiratory sinus arrhythmia (RSA), and

initiate cardiac remodeling pacing comprising increasing the lower rate limit, wherein the cardiac remodeling pacing is configured to provide or cause cardiac remodeling of physical structures of the patient's heart.

2 . The device of claim 1 , wherein adjusting the lower rate limit based on the patient's respiration rate to restore RSA comprises:

determining exhalation based on the patient's monitored respiration;

increasing the lower rate limit during exhalation by a RSA value;

determining inhalation based on the patient's monitored respiration; and

decreasing the lower rate limit during inhalation by the RSA value.

3 . The device of claim 2 , wherein the RSA value is less than or equal to 15 beats per minute.

4 . The device of claim 2 , wherein the RSA value is based on one or more of the patient's heart rate, respiration rate, and activity level.

5 . The device of claim 2 , wherein the computing apparatus is further configured to decrease the RSA value during the cardiac remodeling pacing.

6 . The device of claim 1 , wherein increasing the lower rate limit comprises increasing the lower rate limit to a cardiac remodeling pacing rate.

7 . The device of claim 6 , wherein the cardiac remodeling pacing rate is greater than or equal to 100 beats per minute.

8 . The device of claim 1 , wherein increasing the lower rate limit comprises gradually increasing the lower rate limit according to ramp rate until the lower rate limit is equal to a cardiac remodeling pacing rate.

9 . The device of claim 8 , wherein the ramp rate is greater than or equal to 1 beat per minute increase for every 8 cardiac cycles.

10 . The device of claim 1 , wherein the lower rate limit is initially set to a minimum lower rate limit, wherein the minimum lower rate limit is greater than or equal to 60 beats per minute.

11 . The device of claim 1 , wherein the pacing electrode to be positioned proximate a portion of the cardiac conduction system of the patient's heart to deliver cardiac conduction system pacing therapy to the patient's heart, wherein delivering pacing using at least the pacing electrode based on the lower rate limit comprises delivering cardiac conduction system pacing therapy using at least the pacing electrode based on the lower rate limit.

12 . The device of claim 1 , wherein the cardiac remodeling pacing is initiated in response to inactive times periods when the patient is inactive or asleep.

13 . A method comprising:

delivering pacing to a patient's heart based on a lower rate limit, wherein the lower rate limit is a minimum pacing rate delivered to the patient;

monitoring the patient's respiration;

adjusting the lower rate limit based on the patient's respiration to restore respiratory sinus arrhythmia (RSA); and

initiating cardiac remodeling pacing comprising increasing the lower rate limit, wherein the cardiac remodeling pacing is configured to provide or cause cardiac remodeling of physical structures of the patient's heart.

14 . The method of claim 13 , wherein adjusting the lower rate limit based on the patient's respiration rate to restore RSA comprises:

determining exhalation based on the patient's monitored respiration;

increasing the lower rate limit during exhalation by a RSA value;

determining inhalation based on the patient's monitored respiration; and

decreasing the lower rate limit during inhalation by the RSA value.

15 . The method of claim 14 , wherein the RSA value is less than or equal to 15 beats per minute.

16 . The method of claim 14 , wherein the RSA value is based on one or more of the patient's heart rate, respiration rate, and activity level.

17 . The method of claim 14 , wherein the method further comprises decreasing the RSA value during the cardiac remodeling pacing.

18 . The method of claim 13 , wherein increasing the lower rate limit comprises increasing the lower rate limit to a cardiac remodeling pacing rate.

19 . The method of claim 18 , wherein the cardiac remodeling pacing rate is greater than or equal to 100 beats per minute.

20 . The method of claim 13 , wherein increasing the lower rate limit comprises gradually increasing the lower rate limit according to ramp rate until the lower rate limit is equal to a cardiac remodeling pacing rate.

21 . The method of claim 20 , wherein the ramp rate is greater than or equal to 1 beat per minute increase for every 8 cardiac cycles.

22 . The method of claim 13 , wherein the lower rate limit is initially set to a minimum lower rate limit, wherein the minimum lower rate limit is greater than or equal to 60 beats per minute.

23 . The method of claim 13 , wherein delivering pacing to a patient's heart based on the lower rate limit comprises delivering cardiac conduction system pacing therapy to the patient's cardiac conduction system based on the lower rate limit.

24 . The method of claim 13 , wherein the cardiac remodeling pacing is initiated in response to inactive times periods when the patient is inactive or asleep.

25 . An implantable medical device comprising:

a pacing electrode to be positioned proximate a patient's heart to deliver pacing therapy to the patient's heart;

a respiration sensor to determine a respiration rate of the patient; and

a computing apparatus operably coupled to the pacing electrode and the respiration sensor, the computing apparatus configured to:

switch between delivering support pacing to the patient's heart using at least the pacing electrode based on a support pacing rate or delivering cardiac remodeling pacing to the patient's heart using at least the pacing electrode to provide cardiac remodeling based on a cardiac remodeling pacing rate, wherein the cardiac remodeling pacing rate is greater than the support pacing rate, wherein the cardiac remodeling pacing is configured to provide or cause cardiac remodeling of physical structures of the patient's heart;

monitor the patient's respiration rate using the respiration sensor; and

adjust the cardiac remodeling pacing rate and the support pacing rate based on the patient's respiration rate to restore respiratory sinus arrhythmia (RSA).

26 . The device of claim 25 , wherein adjusting the cardiac remodeling pacing rate and the support pacing rate on the patient's respiration rate to restore RSA comprises:

determining exhalation based on the patient's monitored respiration;

increasing the cardiac remodeling pacing rate and the support pacing rate during exhalation by a RSA value;

determining inhalation based on the patient's monitored respiration; and

decreasing the cardiac remodeling pacing rate and the support pacing rate during inhalation by the RSA value.

27 . The device of claim 26 , wherein the RSA value for cardiac remodeling pacing is less than the RSA value for support pacing.

28 . The device of claim 25 , wherein switching between delivering support pacing using at least the pacing electrode based on a support pacing rate or delivering cardiac remodeling pacing using at least the pacing electrode to provide cardiac remodeling based on a cardiac remodeling pacing rate comprises:

when switching from the support pacing to the cardiac remodeling pacing, gradually increasing the support pacing rate until it equals the cardiac remodeling pacing rate according to an increasing ramp rate; and

when switching from the cardiac remodeling pacing to the support pacing, gradually decreasing the cardiac remodeling pacing rate until it equals the support pacing rate according to a decreasing ramp rate.

29 . The device of claim 28 , wherein a magnitude of the increasing ramp rate is greater than a magnitude of the decreasing ramp rate.

30 . The device of claim 25 , wherein computing apparatus is further configured to determine patient activity,

wherein switching between delivering support pacing using at least the pacing electrode based on a support pacing rate or delivering cardiac remodeling pacing using at least the pacing electrode to provide cardiac remodeling based on a cardiac remodeling pacing rate comprises:

switching from the support pacing to the cardiac remodeling pacing in response to determination of patient inactivity or that the patient is asleep.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2023
From: HOFFMAN, MATTHEW J.; JACKSON, TROY E.; EGGEN, MICHAEL D.
To: MEDTRONIC, INC.
Reel/Frame 062670/0730 →
Continuity (1)
Related Publication 20240252826A1 · Aug 1, 2024
References Cited (117)
US 4428378A · Anderson et al. · 1984 [cited by applicant]
US 4567892A · Plicchi et al. · 1986 [cited by applicant]
US 4644954A · Wittkampf et al. · 1987 [cited by applicant]
US 4867161A · Schaldach · 1989 [cited by applicant]
US 4884576A · Alt · 1989 [cited by applicant]
US 5052388A · Sivula et al. · 1991 [cited by applicant]
US 5052454A · Meinhardt · 1991 [cited by applicant]
US 5097831A · Lekholm · 1992 [cited by applicant]
US 5197467A · Steinhaus et al. · 1993 [cited by applicant]
US 5292340A · Crosby et al. · 1994 [cited by applicant]
US 5318597A · Hauck et al. · 1994 [cited by applicant]
US 5876353A · Riff · 1999 [cited by applicant]
US 6141590A · Renirie · 2000 [cited by applicant]
US 6298268B1 · Ben-Haim et al. · 2001 [cited by applicant]
US 6314322B1 · Rosenberg · 2001 [cited by applicant]
US 6650937B2 · Kerver · 2003 [cited by applicant]
US 7133718B2 · Bakken et al. · 2006 [cited by applicant]
US 7194306B1 · Turcott · 2007 [cited by applicant]
US 7302295B2 · Stahmann · 2007 [cited by applicant]
US 7305266B1 · Kroll · 2007 [cited by applicant]
US 7445605B2 · Overall et al. · 2008 [cited by applicant]
US 7630078B1 · Nabutovsky et al. · 2009 [cited by applicant]
US 7660616B1 · Poore · 2010 [cited by applicant]
US 7769451B2 · Yang et al. · 2010 [cited by applicant]
US 7840246B1 · Poore · 2010 [cited by applicant]
US 7941216B2 · Salo et al. · 2011 [cited by applicant]
US 8027724B2 · Wei et al. · 2011 [cited by applicant]
US 8046069B2 · Kramer et al. · 2011 [cited by applicant]
US 8065003B2 · Kenknight et al. · 2011 [cited by applicant]
US 8126549B2 · Sigg et al. · 2012 [cited by applicant]
US 8306615B2 · Brockway et al. · 2012 [cited by applicant]
US 8386038B2 · Bianchi et al. · 2013 [cited by applicant]
US 8600497B1 · Yang et al. · 2013 [cited by applicant]
US 8798751B2 · Spear et al. · 2014 [cited by applicant]
US 8805497B2 · Dong et al. · 2014 [cited by applicant]
US 8996101B2 · Zhang et al. · 2015 [cited by applicant]
US 9002454B2 · Ghosh et al. · 2015 [cited by applicant]
US 9101772B2 · Kleckner et al. · 2015 [cited by applicant]
US 9155896B2 · Salo · 2015 [cited by applicant]
US 9320906B2 · Maskara et al. · 2016 [cited by applicant]
US 9403016B2 · Meyer · 2016 [cited by applicant]
US 9956416B2 · Ghosh et al. · 2018 [cited by applicant]
US 10029103B2 · Sweeney · 2018 [cited by applicant]
US 10702698B2 · Zhao et al. · 2020 [cited by applicant]
US 11207529B2 · Zhou · 2021 [cited by applicant]
US 11311734B2 · Zhou · 2022 [cited by applicant]
US 20030158584A1 · Cates et al. · 2003 [cited by applicant]
US 20040199210A1 · Shelchuk · 2004 [cited by applicant]
US 20060100668A1 · Ben-David · 2006 [cited by applicant]
US 20060178586A1 · Dobak · 2006 [cited by applicant]
US 20060224196A1 · Hettrick et al. · 2006 [cited by applicant]
US 20060224203A1 · Hettrick et al. · 2006 [cited by applicant]
US 20060247692A1 · Yang et al. · 2006 [cited by applicant]
US 20070150017A1 · Salo · 2007 [cited by applicant]
US 20070203522A1 · Hettrick et al. · 2007 [cited by applicant]
US 20080051840A1 · Moaddeb et al. · 2008 [cited by applicant]
US 20080114408A1 · Shuros et al. · 2008 [cited by applicant]
US 20080119898A1 · Ben-David et al. · 2008 [cited by applicant]
US 20080132800A1 · Hettrick et al. · 2008 [cited by applicant]
US 20080188721A1 · Patangay et al. · 2008 [cited by applicant]
US 20080234776A1 · Kenknight et al. · 2008 [cited by applicant]
US 20090005831A1 · Wilson et al. · 2009 [cited by applicant]
US 20090093857A1 · Markowitz et al. · 2009 [cited by applicant]
US 20090234401A1 · Zielinski et al. · 2009 [cited by applicant]
US 20100016923A1 · Rousso et al. · 2010 [cited by applicant]
US 20100082077A1 · Bruns · 2010 [cited by applicant]
US 20100152802A1 · Min · 2010 [cited by applicant]
US 20100152804A1 · Kleckner et al. · 2010 [cited by applicant]
US 20120010674A1 · Pastore et al. · 2012 [cited by applicant]
US 20120035679A1 · Dagan et al. · 2012 [cited by applicant]
US 20120101541A1 · Corbucci et al. · 2012 [cited by applicant]
US 20120150252A1 · Feldman et al. · 2012 [cited by applicant]
US 20120290032A1 · Cho · 2012 [cited by examiner]
US 20120290033A1 · Cho · 2012 [cited by examiner]
US 20120303078A1 · Li et al. · 2012 [cited by applicant]
US 20120323099A1 · Mothilal et al. · 2012 [cited by applicant]
US 20130237873A1 · Zhang et al. · 2013 [cited by applicant]
US 20140100621A1 · Feldman et al. · 2014 [cited by applicant]
US 20140277237A1 · Maskara et al. · 2014 [cited by applicant]
US 20140277240A1 · Maskara et al. · 2014 [cited by applicant]
US 20140303078A1 · Melton et al. · 2014 [cited by applicant]
US 20150250428A1 · Zhang et al. · 2015 [cited by applicant]
US 20160361559A1 · Scharmer · 2016 [cited by applicant]
US 20170079598A1 · Stolen et al. · 2017 [cited by applicant]
US 20170290550A1 · Perschbacher et al. · 2017 [cited by applicant]
US 20180126171A1 · Herrmann et al. · 2018 [cited by applicant]
US 20190167991A1 · Stahmann et al. · 2019 [cited by applicant]
US 20190168007A1 · Stahmann et al. · 2019 [cited by applicant]
US 20190201696A1 · Koop et al. · 2019 [cited by applicant]
US 20190336096A1 · Itu et al. · 2019 [cited by applicant]
US 20190381322A1 · Sharma · 2019 [cited by examiner]
US 20190381323A1 · Sharma et al. · 2019 [cited by applicant]
US 20200038663A1 · Meyer · 2020 [cited by applicant]
US 20200289829A1 · Ghosh · 2020 [cited by applicant]
EP 2809393 · 2014 [cited by applicant]
EP 4054708B1 · 2023 [cited by applicant]
WO 2005039690 · 2005 [cited by applicant]
WO 2005118062 · 2005 [cited by applicant]
WO 2008109040 · 2008 [cited by applicant]
WO 2013010165 · 2013 [cited by applicant]
WO 2018067931 · 2018 [cited by applicant]
International Search Report and Written Opinion for PCT/IB2024/050345 dated Mar. 26, 2024 (11 pages). [cited by applicant]
Blain et al., “Influences of Breathing Patterns on Respiratory Sinus Arrhythmia in Humans During Exercise”, Am J Physiol Heart Circ Physiol 288, H887-H895, 2005. [cited by applicant]
Boehmer et al., “A Multisensor Algorithm Predicts Heart Failure Events in Patients with Implanted Devices: Results from the MultiSense Study, JACC”, Heart Failure, vol. 5, No. 3, 2017, pp. 216-225. [cited by applicant]
Gimelli et al., “CRT in Patients with Heart Failure: Time Course of Perfusion and Wall Motion Changes,” 2010, Cardiology Research and Practice, 2010:981064, 5 pages. [cited by applicant]
Heidenreich, P.A., et al., Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail, 2013. 6(3): p. 606-19. [cited by applicant]
Hirsch et al., “Respiratory Sinus Arrhythmia in Humans: How Breathing Pattern Modulates Heart Rate,” Department of Physiology, State University of New York at Buffalo, School of Medicine, Buffalo, New York, pp. H620-H62… [cited by applicant]
Infeld, Margaret, et al. “Personalized pacing (myPace): a new paradigm for diastolic heart failure treatment.” Journal of the American College of Cardiology 77.18_Supplement_1 (2021): 223-223. [cited by applicant]
International Search Report and Written Opinion for PCT/US2021/037229 dated Oct. 29, 2019 (21 pages). [cited by applicant]
Jarvelainen et al., “Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy,” Pharmacol Rev, 2009, 61:198-223. [cited by applicant]
Jian, A., et al. “Association Between Heart Rate Variability and Echocardiographic Parameters in Heart Failure with Reduced and Preserved Ejection Fraction.” Heart, Lung and Circulation 28 (2019): S161. [cited by applicant]
Klein, F.J., et al., Heart-Rate Induced Modifications of Concentric Left Ventricular Hypertrophy—Exploration of a Novel Therapeutic Concept. Am J Physiology, Published Sep. 2, 2016 vol. No. DOI: 10.1152/ajpheart.00301.2… [cited by applicant]
Owan, T.E., et al., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med, 2006. 355(3): p. 251-9. [cited by applicant]
Shanks, J., et al. “Reverse re-modelling chronic heart failure by reinstating heart rate variability.” Basic Research in Cardiology 117.1 (2022): 1-16. [cited by applicant]
Solomon et al., “Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome”, American Heart Association, vol. 122, , Sep. 7, 2010, pp. 985-992. [cited by applicant]
Wahlberg K, Arnold ME, Lustgarten D, Meyer M. Effects of a Higher Heart Rate on Quality of Life and Functional Capacity in Patients With Left Ventricular Diastolic Dysfunction. Am J Cardiol. 2019;124(7):1069-75. [cited by applicant]
Westermann et al., “Role of left ventricular stiffness in heart failure with normal ejection fraction,” Circulation, Apr. 22, 2008: 117 (16):2051-60. [cited by applicant]